Ann: Promising Interim Results from TAVR Animal Study, page-35

Game changer or not?

Particularly relevant will be ‘How compelling these results are to interested parties’, imo.

Compelling enough to front up serious funds?, 20 mill plus,?, R&D costs being covered a given, the game decider, imo, will be the amount of upfront funds.

Lets see what comes out in the wash, all noise at the minute, however ‘postive’ the announcement is.

At this time I feel, as far as retail investors are concerned, that it is a short term carrot to ‘keep current  retail investors appeased, ....... without sp appreciation that will be all it is, a dangling carrot.

Not one single  postive announcement has seen any sp appreciation in a very long time, will this announcement do it or not?

No doubts that SB and SIO will be satisfied with progress, their time frames can and are, presumably, in the long term, that will not, imo, be beneficial to retail holders if funds run out again in the interim!


One more CR this year, at current sp, will be a death knell for retail holders, SB and SIO will likely buy in and effectively ‘own’ the company.


Cant but help feel that retail holders will be left behind once again.